糖尿病低血糖高危人群的管理:内分泌学会临床实践指南
该指南由内分泌学会制定,采用GRADE方法,针对糖尿病患者低血糖风险与预防提出10个临床问题并形成10条推荐。推荐包括:对1型糖尿病(T1D)患者使用实时持续葡萄糖监测(CGM)和算法驱动的胰岛素泵(条件推荐);对低血糖高危的2型糖尿病门诊患者使用CGM(条件推荐);使用长效和速效胰岛素类似物(条件推荐);对特定住院高危人群启动并继续CGM(条件推荐);对低血糖高危者开展结构化糖尿病教育项目(强推荐);使用无需重构的胰高血糖素制剂而非需重构制剂处理严重门诊低血糖(强推荐);对每日多次注射的T1D患者使用实时CGM(强推荐);利用电子健康记录数据的住院血糖管理项目降低低血糖风险(强推荐)。这些推荐考虑了关键结局及可行性、患者价值观与偏好等实施因素,可用于指导临床实践和医疗系统改进。
要点
- 对低血糖高危的糖尿病患者,推荐结构化糖尿病教育项目(强推荐)。
- 处理成人及儿童严重门诊低血糖,推荐使用无需重构的胰高血糖素制剂而非需重构制剂(强推荐)。
- 对每日多次注射胰岛素的T1D患者,推荐使用实时CGM(强推荐)。
- 推荐利用电子健康记录数据的住院血糖管理项目以降低低血糖风险(强推荐)。
- 对T1D患者,条件推荐使用实时CGM和算法驱动的胰岛素泵;对低血糖高危的2型糖尿病门诊患者,条件推荐使用CGM;条件推荐使用长效和速效胰岛素类似物;对特定住院高危人群,条件推荐启动并继续CGM。
适用人群与场景
- 成人及儿童糖尿病患者,尤其是使用胰岛素和磺脲类药物(SU)等增加低血糖风险药物者。
- 门诊场景:低血糖高危的2型糖尿病门诊患者;T1D患者(使用实时CGM、算法驱动胰岛素泵或每日多次注射者)。
- 住院场景:特定住院人群,低血糖高危者(启动并继续CGM)。
处置流程与药物剂量
- 对低血糖高危者开展结构化糖尿病教育项目(强推荐)。
- 处理成人及儿童严重门诊低血糖,使用无需重构的胰高血糖素制剂而非需重构制剂(强推荐)。
- 对每日多次注射的T1D患者使用实时CGM(强推荐)。
- 利用电子健康记录数据的住院血糖管理项目以降低低血糖风险(强推荐)。
- 对T1D患者使用实时CGM和算法驱动的胰岛素泵(条件推荐)。
- 对低血糖高危的2型糖尿病门诊患者使用CGM(条件推荐)。
- 使用长效和速效胰岛素类似物(条件推荐)。
- 对特定住院高危人群启动并继续CGM(条件推荐)。
研究设计与关键结果
- 制定机构:内分泌学会;方法:多学科专家组(包括患者代表和方法学家)确定10个低血糖相关临床问题,进行系统评价,采用GRADE方法评估证据确定性并形成推荐。
- 共形成10条推荐:条件推荐包括T1D患者使用实时CGM和算法驱动胰岛素泵、低血糖高危的2型糖尿病门诊患者使用CGM、使用长效和速效胰岛素类似物、特定住院高危人群启动并继续CGM;强推荐包括结构化糖尿病教育项目、使用无需重构的胰高血糖素制剂而非需重构制剂处理成人及儿童严重门诊低血糖、每日多次注射的T1D患者使用实时CGM、利用电子健康记录数据的住院血糖管理项目降低低血糖风险。
证据类型、等级与局限
- 证据类型:临床实践指南;采用GRADE方法评估证据确定性和推荐强度。
- 推荐强度:强推荐和条件推荐(如原文所述)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对低血糖高危的糖尿病患者,应实施结构化糖尿病教育项目(强推荐)。
- 处理成人及儿童严重门诊低血糖,应使用无需重构的胰高血糖素制剂而非需重构制剂(强推荐)。
- 对每日多次注射的T1D患者,应使用实时CGM(强推荐)。
- 应利用电子健康记录数据的住院血糖管理项目以降低低血糖风险(强推荐)。
- 对T1D患者,可考虑使用实时CGM和算法驱动的胰岛素泵(条件推荐)。
- 对低血糖高危的2型糖尿病门诊患者,可考虑使用CGM(条件推荐)。
- 可考虑使用长效和速效胰岛素类似物(条件推荐)。
- 对特定住院高危人群,可考虑启动并继续CGM(条件推荐)。
指南或共识出处
- Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline(J Clin Endocrinol Metab)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: Hypoglycemia in people with diabetes is common, especially in those taking medications such as insulin and sulfonylureas (SU) that place them at higher risk. Hypoglycemia is associated with distress in those with diabetes and their families, medication nonadherence, and disruption of life and work, and it leads to costly emergency department visits and hospitalizations, morbidity, and mortality.
OBJECTIVE: To review and update the diabetes-specific parts of the 2009 Evaluation and Management of Adult Hypoglycemic Disorders: Endocrine Society Clinical Practice Guideline and to address developing issues surrounding hypoglycemia in both adults and children living with diabetes. The overriding objectives are to reduce and prevent hypoglycemia.
METHODS: A multidisciplinary panel of clinician experts, together with a patient representative, and methodologists with expertise in evidence synthesis and guideline development, identified and prioritized 10 clinical questions related to hypoglycemia in people living with diabetes. Systematic reviews were conducted to address all the questions. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the certainty of evidence and make recommendations.
RESULTS: The panel agreed on 10 questions specific to hypoglycemia risk and prevention in people with diabetes for which 10 recommendations were made. The guideline includes conditional recommendations for use of real-time continuous glucose monitoring (CGM) and algorithm-driven insulin pumps in people with type 1 diabetes (T1D), use of CGM for outpatients with type 2 diabetes at high risk for hypoglycemia, use of long-acting and rapid-acting insulin analogs, and initiation of and continuation of CGM for select inpatient populations at high risk for hypoglycemia. Strong recommendations were made for structured diabetes education programs for those at high risk for hypoglycemia, use of glucagon preparations that do not require reconstitution vs those that do for managing severe outpatient hypoglycemia for adults and children, use of real-time CGM for individuals with T1D receiving multiple daily injections, and the use of inpatient glycemic management programs leveraging electronic health record data to reduce the risk of hypoglycemia.
CONCLUSION: The recommendations are based on the consideration of critical outcomes as well as implementation factors such as feasibility and values and preferences of people with diabetes. These recommendations can be used to inform clinical practice and health care system improvement for this important complication for people living with diabetes.
参考来源
- McCall AL, Lieb DC, Gianchandani R, et al. Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2023. PMID: 36477488. doi:10.1210/clinem/dgac596
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。